These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36242824)

  • 1. The use of early neuromuscular blockage in acute respiratory distress syndrome: A systematic review and meta-analyses of randomized clinical trials.
    Savoie-White FH; Tremblay L; Menier CA; Duval C; Bergeron F; Tadrous M; Tougas J; Guertin JR; Ugalde PA
    Heart Lung; 2023; 57():186-197. PubMed ID: 36242824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
    Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M;
    Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults.
    Dushianthan A; Cusack R; Burgess VA; Grocott MP; Calder PC
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012041. PubMed ID: 30677127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Lyu T; Lee YS; Dhanvijay S; Freebairn R
    Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
    Shao S; Kang H; Tong Z
    BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
    Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
    Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
    Hua Y; Ou X; Li Q; Zhu T
    PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statin in the treatment of ALI/ARDS: a systematic review and Meta-analysis based on international databases].
    Chen M; Lu J; Chen Q; Cheng L; Geng Y; Jiang H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):51-56. PubMed ID: 28459404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.
    Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W;
    Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
    Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of different positive end-expiratory pressure selection strategies with all-cause mortality in adult patients with acute respiratory distress syndrome.
    Tisminetzky M; Dianti J; Ferreyro BL; Angriman F; Del Sorbo L; Sud S; Talmor D; Fan E; Ferguson ND; Serpa Neto A; Adhikari NKJ; Goligher EC
    Syst Rev; 2021 Aug; 10(1):225. PubMed ID: 34384488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
    Torbic H; Krishnan S; Harnegie MP; Duggal A
    Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prone position for acute respiratory failure in adults.
    Bloomfield R; Noble DW; Sudlow A
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008095. PubMed ID: 26561745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systematic evaluation of neuromuscular blocking agents on prognosis of patients with moderate to severe acute respiratory distress syndrome].
    Gao ZW; Zhao HM; Sun QS; Sun H; Huang YZ; Zheng P
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3819-3825. PubMed ID: 31874521
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.
    Tao W; Yang LQ; Gao J; Shao J
    J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.